Sağlık Sitelerinden Haberler


        
 
Bilgi:
Etiketler:
Yazarın adı:
Yazarın soyadı:


EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021
The first U.S. multisite test-negative design vaccine effectiveness study among HCP found a single dose of Pfizer-BioNTech or Moderna COVID-19 vaccines to be 82% effective against symptomatic COVID-19 and 2 doses to be 94% effective.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=422061
Etiketler:

EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421539
Etiketler:

EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021
In May 2021, after a systematic review of all available data, the Advisory Committee on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in adolescents aged 12-15 years for the prevention of COVID-19.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=422060
Etiketler:

EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 - Colorado, January-March 2021
On January 24, the Colorado Department of Public Health and Environment (CDPHE) identified the first Colorado case of COVID-19 attributed to the B.1.427 and B.1.429 variants. To improve convenience sampling to identify and track emerging variants, CDPHE established a 30-site statewide sentinel surveillance system.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421658
Etiketler:

EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021
Five mass vaccination sites reported 64 anxiety-related events, including 17 events of syncope (fainting) after receipt of Janssen COVID-19 vaccine. The reporting rates of syncope to VAERS after Janssen COVID-19 and influenza vaccines (2019-20) were 8.2 and 0.05 per 100,000 doses, respectively.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421542
Etiketler:

EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021
In U.S. hospitals during January-March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421438
Etiketler:

EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021
This report describes an investigation in Maryland of two linked clusters of COVID-19 cases identified as the B.1.351 variant.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421458
Etiketler:

EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021
Twenty-two possible breakthrough SARS-CoV-2 infections occurred among fully vaccinated persons ≥14 days after their second dose of COVID-19 vaccine. Two thirds of persons were asymptomatic. A minority of persons with breakthrough infection experienced mild to moderate COVID-19-like symptoms; two COVID-19-related hospitalizations and one death occurred. No facility-associated secondary transmission was identified.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420772
Etiketler:

EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021
In a COVID-19 outbreak at a Kentucky skilled nursing facility involving a newly introduced variant to the region, unvaccinated residents and health care personnel (HCP) had 3.0 and 4.1 times the risk of infection as did vaccinated residents and HCP. Vaccine was 86.5% protective against symptomatic illness among residents and 87.1% protective among HCP.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=420773
Etiketler:

EklenmeTarihi: 24 Mayıs 2022, Salı, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021
The Advisory Committee on Immunization Practices concluded that the benefits of resuming Janssen COVID-19 vaccination among persons aged ≥18 years outweighed the risks and reaffirmed its interim recommendation under FDA's Emergency Use Authorization, which includes a new warning for rare clotting events among women aged 18-49 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421416
Etiketler: